Condition: Obesity & Overweight · Mobility Disability · HOMA-IR · Sponsor: Veru Inc.
The primary objective of this study is to assess the effect of enobosarm on total body weight
This description comes directly from the study's public registry record.
Gary Barnette · 8006069382 · veruclinicaltrials@verupharma.com
Domingo Rodriguez · 8006069382 · veruclinicaltrials@verupharma.com
Always discuss trial participation with your own doctor first.
| DM Clinical Research - Phoenix | Phoenix, Arizona, United States | Recruiting |
| DM Clinical Research - MIA | Doral, Florida, United States | Recruiting |
| Universal Axon Clinical Research (Rovia - UACR) | Doral, Florida, United States | Recruiting |
| Paramo Health | Miami, Florida, United States | Recruiting |
| IMIC Research a Rovia Clinical Research Company | Miami, Florida, United States | Recruiting |
| Paramo Health | Miami, Florida, United States | Recruiting |
| UD Research | Atlanta, Georgia, United States | Withdrawn |
| Pennington Biomedical Research Center | Baton Rouge, Louisiana, United States | Recruiting |
| Centennial Medical Group (CMG) | Columbia, Maryland, United States | Recruiting |
| SKY Integrative Medical Center | Ridgeland, Mississippi, United States | Recruiting |
| ALSA Research | New York, New York, United States | Recruiting |
| Coastal Research Institute, LLC | Fayetteville, North Carolina, United States | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07446998